BALCX | MTRBX | BALCX / MTRBX | |
Total Expense Ratio | 1.31 | 1.47 | 89% |
Annual Report Gross Expense Ratio | 1.31 | 1.47 | 89% |
Fund Existence | 25 years | 32 years | - |
Gain YTD | 12.067 | 8.131 | 148% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 1000 | 25% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 266B | 7.75B | 3,434% |
Annual Yield % from dividends | 1.12 | 1.57 | 71% |
Returns for 1 year | 6.66 | 0.14 | 4,662% |
Returns for 3 years | 47.42 | 18.86 | 251% |
Returns for 5 years | 35.48 | 6.48 | 548% |
Returns for 10 years | 66.70 | 29.60 | 225% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
OSVCX | 17.97 | N/A | N/A |
JPMorgan Small Cap Value C | |||
GCTCX | 47.64 | N/A | N/A |
Goldman Sachs US Tax-Managed Eq C | |||
MSSLX | 10.34 | N/A | N/A |
Morgan Stanley Inst Inception L | |||
RWIGX | 74.12 | -1.92 | -2.52% |
American Funds Capital World Gr&Inc R6 | |||
MCYIX | 13.29 | -0.50 | -3.63% |
NYLI Candriam Emerging Markets Eq Cl I |